Sars-Cov2 Not Detected in a Pediatric Population With Acute Respiratory Infection in Primary Care in Central and Southern Italy From November 2019 to Early March 2020
- PMID: 34046372
- PMCID: PMC8147864
- DOI: 10.3389/fped.2021.620598
Sars-Cov2 Not Detected in a Pediatric Population With Acute Respiratory Infection in Primary Care in Central and Southern Italy From November 2019 to Early March 2020
Abstract
Background: In December 2019, a novel coronavirus named SARS-CoV-2 started circulating in China and this led to a major epidemic in Northern Italy between February and May 2020. Young children (aged <5 years) seem to be less affected by this coronavirus disease (COVID-19) compared to adults, although there is very little information on the circulation of this new virus among children in Italy. We retrospectively tested nasopharyngeal swabs for SARS-CoV-2 in samples collected in young children between November, 2019 and March, 2020 in the context of the RSV ComNet study. Methods: Two networks of primary care pediatricians in Lazio (Central Italy) and Puglia (Southern Italy) collected nasopharyngeal swabs from children, aged <5 years, presenting with symptoms for an acute respiratory infection (ARI). The RSV ComNet study is a multicenter study implemented to estimate the burden of RSV in young children (aged <5 years) in the community. Swabs were sent to a central reference laboratory and tested for 14 respiratory viruses through RT-PCR. All collected samples were retrospectively tested for SARS-CoV-2 using RT-PCR (Istituto Superiore di Sanità protocol). Results: A total of 293 children with ARI were identified in the two participating networks. The highest number of cases were recruited in weeks 51/2019 and 3/2020. The majority of patients (57%) came from the Lazio region. All of the 293 samples tested negative for SARS-Cov2. Rhinovirus was the most frequently detected virus (44%), followed by RSV (41%) and influenza viruses (14%). Conclusions: Our study shows that in Lazio (a region of intermediate SARS-COV-2 incidence) and Puglia (a region of low incidence), the SARS-Cov2 virus did not circulate in a sample of ARI pediatric cases consulting primary care pediatricians between November 2019 and March 2020.
Keywords: ARI; RSV; SARS-CoV2; epidemiology; pediatric cases; primary care.
Copyright © 2021 Rizzo, Loconsole, Pandolfi, Ciofi Degli Atti, van Summeren, Paget, Russo, Campagna, Croci, Gesualdo, Concato, Linardos, Bartolucci, Ciampini, Muda, Raponi and Chironna.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.PLoS One. 2021 Dec 7;16(12):e0260947. doi: 10.1371/journal.pone.0260947. eCollection 2021. PLoS One. 2021. PMID: 34874956 Free PMC article.
-
Changes in the Circulation of Common Respiratory Pathogens among Hospitalized Patients with Influenza-like Illnesses in the Lazio Region (Italy) during Fall Season of the Past Three Years.Int J Environ Res Public Health. 2022 May 13;19(10):5962. doi: 10.3390/ijerph19105962. Int J Environ Res Public Health. 2022. PMID: 35627498 Free PMC article.
-
[Investigation of pathogenic agents causing acute respiratory tract infections in pediatric patients in a children's hospital assigned for case screening in Beijing during the outbreak of COVID-19].Zhonghua Er Ke Za Zhi. 2020 Aug 2;58(8):635-639. doi: 10.3760/cma.j.cn112140-20200426-00437. Zhonghua Er Ke Za Zhi. 2020. PMID: 32842383 Chinese.
-
Assessing respiratory viral exclusion and affinity interactions through co-infection incidence in a pediatric population during the 2022 resurgence of influenza and RSV.Front Cell Infect Microbiol. 2023 Jun 14;13:1208235. doi: 10.3389/fcimb.2023.1208235. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37389220 Free PMC article. Review.
-
Effects of Non-Pharmacological Interventions on Respiratory Viruses Other Than SARS-CoV-2: Analysis of Laboratory Surveillance and Literature Review From 2018 to 2021.J Korean Med Sci. 2022 May 30;37(21):e172. doi: 10.3346/jkms.2022.37.e172. J Korean Med Sci. 2022. PMID: 35638198 Free PMC article. Review.
Cited by
-
A serological investigation in Southern Italy: was SARS-CoV-2 circulating in late 2019?Hum Vaccin Immunother. 2022 Nov 30;18(5):2047582. doi: 10.1080/21645515.2022.2047582. Epub 2022 Mar 15. Hum Vaccin Immunother. 2022. PMID: 35289714 Free PMC article.
-
Human Respiratory Syncytial Virus Epidemiological Burden in Pediatric Outpatients in Italy: A Systematic Review.Vaccines (Basel). 2023 Sep 14;11(9):1484. doi: 10.3390/vaccines11091484. Vaccines (Basel). 2023. PMID: 37766160 Free PMC article. Review.
-
Epidemiology and clinical features of SARS-CoV-2 infection in children and adolescents in the pre-Omicron era: A global systematic review and meta-analysis.J Glob Health. 2024 Mar 1;14:05003. doi: 10.7189/jogh.14.05003. J Glob Health. 2024. PMID: 38419461 Free PMC article.
-
RSV Disease Burden in Primary Care in Italy: A Multi-Region Pediatric Study, Winter Season 2022-2023.Influenza Other Respir Viruses. 2024 Apr;18(4):e13282. doi: 10.1111/irv.13282. Influenza Other Respir Viruses. 2024. PMID: 38622776 Free PMC article.
References
-
- WHO . WHO Director-General's Opening Remarks at the Media Briefing on COVID-19. (2020). Available online at: https://www.who.int/director-general/speeches/detail/who-director-genera... (accessed November 16, 2020)
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous